Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpmorgan Clav Regulatory News (JCH)

Share Price Information for Jpmorgan Clav (JCH)

Share Price is delayed by 15 minutes
Get Live Data
896.00    2.00 (0.22%)
Bid:
894.00
Ask:
900.00
Spread: 6.00 (0.671%)
Market Cap: £487.52m
JCH Live PriceLast checked at - London Stock Exchange

Intraday Jpmorgan Clav Share Chart

Dividend Declaration

10 Oct 2025 08:49

RNS Number : 9100C
JPMorgan Claverhouse IT PLC
10 October 2025
 

 

 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

JPMORGAN CLAVERHOUSE INVESTMENT TRUST PLC

(the 'Company')

 

Third quarterly interim dividend

 

 

Legal Entity Identifier: 549300NFZYYFSCD52W53

Information disclosed in accordance with DTR 6.1.13

 

 

The Directors have declared that a third quarterly interim dividend of 8.40 pence per share for the year ending 31st December 2025 will be paid on 1st December 2025 to shareholders on the register at the close of business on 31st October 2025. The ex-dividend date will be 30th October 2025.

 

As announced in the Annual Report, the Board intends to raise the first three quarterly interim dividends in 2025 to 8.40p per share, from 8.25p per share in the previous financial year, subject to any unforeseen factors and the financial position and performance of the Company at the relevant time.

 

The Company has increased its total annual dividend for 52 consecutive years and the Board's dividend policy remains to seek to increase the dividend each year and, taking a run of years together, to increase dividends at a rate close to, or above, the rate of inflation.

 

The Company offers the option for shareholders to invest their dividend in a Dividend Reinvestment Plan ('DRIP'), which is managed by the Company's registrar. For details on the DRIP, please contact the Company's Registrar, Computershare Investor Services PLC.

 

The key dates relating to this dividend are given below:

Ex-dividend date

30th October 2025

Record date

31st October 2025

Last date for DRIP election

10th November 2025

Payment date

1st December 2025

 

 

10th October 2025

 

For further information, please contact:

 Anmol Dhillon

 JPMorgan Funds Limited

 Company Secretary

 0800 20 40 20 (or +44 1268 44 44 70)

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVGPGRCUUPAUMU
Date   Source Headline
24th Sep 202411:26 amRNSNet Asset Value(s)
23rd Sep 202411:22 amRNSGearing Announcement
23rd Sep 202410:57 amRNSNet Asset Value(s)
20th Sep 202410:51 amRNSNet Asset Value(s)
19th Sep 202410:34 amRNSNet Asset Value(s)
19th Sep 20249:45 amRNSDirector/PDMR Shareholding
18th Sep 202410:38 amRNSNet Asset Value(s)
17th Sep 20244:58 pmRNSTransaction in Own Shares
17th Sep 202410:58 amRNSNet Asset Value(s)
16th Sep 202411:33 amRNSGearing announcement
16th Sep 202410:51 amRNSNet Asset Value(s)
13th Sep 202410:54 amRNSNet Asset Value(s)
12th Sep 20245:30 pmRNSDirector/PDMR Shareholding
12th Sep 202410:36 amRNSNet Asset Value(s)
11th Sep 202411:11 amRNSTen Largest Investments
11th Sep 202410:29 amRNSNet Asset Value(s)
10th Sep 202410:41 amRNSNet Asset Value(s)
9th Sep 202412:00 pmRNSGearing Announcement
9th Sep 202410:59 amRNSNet Asset Value(s)
6th Sep 202410:54 amRNSNet Asset Value(s)
5th Sep 202410:42 amRNSNet Asset Value(s)
4th Sep 202410:49 amRNSNet Asset Value(s)
3rd Sep 202411:20 amRNSNet Asset Value(s)
2nd Sep 20242:01 pmRNSGearing Announcement
2nd Sep 202412:09 pmRNSNet Asset Value(s)
2nd Sep 20249:20 amRNSTotal Voting Rights
30th Aug 20245:10 pmRNSTransaction in Own Shares
30th Aug 202411:27 amRNSNet Asset Value(s)
29th Aug 202410:49 amRNSNet Asset Value(s)
28th Aug 202411:06 amRNSNet Asset Value(s)
27th Aug 20241:01 pmRNSGearing Announcement
27th Aug 202411:58 amRNSNet Asset Value(s)
23rd Aug 202410:41 amRNSNet Asset Value(s)
22nd Aug 202410:22 amRNSNet Asset Value(s)
21st Aug 202410:23 amRNSNet Asset Value(s)
20th Aug 202410:56 amRNSNet Asset Value(s)
19th Aug 202411:48 amRNSGearing Announcement
19th Aug 202411:04 amRNSNet Asset Value(s)
16th Aug 202410:40 amRNSNet Asset Value(s)
15th Aug 202411:12 amRNSNet Asset Value(s)
14th Aug 202411:05 amRNSNet Asset Value(s)
13th Aug 202410:29 amRNSNet Asset Value(s)
12th Aug 20243:21 pmRNSTen Largest Investments
12th Aug 202410:50 amRNSGearing Announcement
12th Aug 202410:32 amRNSNet Asset Value(s)
9th Aug 202411:52 amRNSHalf-year Report
9th Aug 202410:45 amRNSNet Asset Value(s)
8th Aug 202410:29 amRNSNet Asset Value(s)
7th Aug 202410:33 amRNSNet Asset Value(s)
6th Aug 202410:50 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.